Fusion Antibodies plc (AIM:FAB)
13.16
-0.10 (-0.72%)
Jan 22, 2026, 4:26 PM GMT
Fusion Antibodies Employees
Fusion Antibodies had 24 employees as of March 31, 2025. The number of employees decreased by 3 or -11.11% compared to the previous year.
Employees
24
Change (1Y)
-3
Growth (1Y)
-11.11%
Revenue / Employee
66.50K GBP
Profits / Employee
-61.13K GBP
Market Cap
15.06M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 24 | -3 | -11.11% |
| Mar 31, 2024 | 27 | -21 | -43.75% |
| Mar 31, 2023 | 48 | -7 | -12.73% |
| Mar 31, 2022 | 55 | 0 | - |
| Mar 31, 2021 | 55 | 11 | 25.00% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IXICO | 79 |
| Arecor Therapeutics | 44 |
| Oxford BioDynamics | 41 |
| Aptamer Group | 31 |
| Poolbeg Pharma | 16 |
| Futura Medical | 14 |
| OptiBiotix Health | 10 |
| ImmuPharma | 6 |